Advertisement
Screener

4D Molecular Therapeutics, Inc. (FDMT) Auditor

4D Molecular Therapeutics, Inc. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-03-18: Fiscal year end 2025-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 238; Location San Jose, California.
  • 2025-02-28: Fiscal year end 2024-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 238; Location San Jose, California.
  • 2024-02-29: Fiscal year end 2023-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 238; Location San Jose, California.
  • 2023-03-15: Fiscal year end 2022-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 238; Location San Jose, California.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-03-182025-12-31PricewaterhouseCoopers LLP238San Jose, CaliforniaNo
2025-02-282024-12-31PricewaterhouseCoopers LLP238San Jose, CaliforniaYes
2024-02-292023-12-31PricewaterhouseCoopers LLP238San Jose, CaliforniaNo
2023-03-152022-12-31PricewaterhouseCoopers LLP238San Jose, CaliforniaNo
2022-03-282021-12-31PricewaterhouseCoopers LLP238San Jose, CaliforniaNo
2021-03-252020-12-31PricewaterhouseCoopers LLPSan Jose, CaliforniaNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
Solid Biosciences Inc. (SLDB)United States$0.802B-5.07
Aura Biosciences, Inc. (AURA)United States$0.639B-5.61
Attovia Therapeutics, Inc. (ATTO)United States$0.828B
Candel Therapeutics, Inc. (CADL)United States$0.885B-8.86
Sana Biotechnology, Inc. (SANA)United States$0.886B-4.92
Allogene Therapeutics, Inc. (ALLO)United States$0.574B-4.33
Prime Medicine, Inc. (PRME)United States$0.557B-3.54
Autolus Therapeutics plc (AUTL)$0.506B-1.52
Odyssey Therapeutics, Inc. (ODTX)United States$0.960B
Entera Bio Ltd. (ENTX)$0.485B